BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29777040)

  • 1. OBE022, an Oral and Selective Prostaglandin F
    Pohl O; Chollet A; Kim SH; Riaposova L; Spézia F; Gervais F; Guillaume P; Lluel P; Méen M; Lemaux F; Terzidou V; Bennett PR; Gotteland JP
    J Pharmacol Exp Ther; 2018 Aug; 366(2):349-364. PubMed ID: 29777040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2α receptor antagonist tocolytic: A first-in-human trial in healthy postmenopausal women.
    Pohl O; Marchand L; Gotteland JP; Coates S; Täubel J; Lorch U
    Br J Clin Pharmacol; 2018 Aug; 84(8):1839-1855. PubMed ID: 29708281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone.
    Pohl O; Marchand L; Gotteland JP; Coates S; Täubel J; Lorch U
    Br J Clin Pharmacol; 2019 Jul; 85(7):1516-1527. PubMed ID: 30891820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of the Cardiac Safety of PGF
    Täubel J; Lorch U; Coates S; Fernandes S; Foley P; Ferber G; Gotteland JP; Pohl O
    Clin Pharmacol Drug Dev; 2018 Nov; 7(8):889-900. PubMed ID: 29489066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrest of preterm labor in rat and mouse by an oral and selective nonprostanoid antagonist of the prostaglandin F2alpha receptor (FP).
    Cirillo R; Tos EG; Page P; Missotten M; Quattropani A; Scheer A; Schwarz MK; Chollet A
    Am J Obstet Gynecol; 2007 Jul; 197(1):54.e1-9. PubMed ID: 17618756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocolytic effect of a selective FP receptor antagonist in rodent models reveals an innovative approach to the treatment of preterm labor.
    Chollet A; Tos EG; Cirillo R
    BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S16. PubMed ID: 17570160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THG113: a novel selective FP antagonist that delays preterm labor.
    Peri KG; Quiniou C; Hou X; Abran D; Varma DR; Lubell WD; Chemtob S
    Semin Perinatol; 2002 Dec; 26(6):389-97. PubMed ID: 12537309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effects of cyclooxygenase inhibitors on myometrial contraction and constriction of ductus arteriosus in rats.
    Karadas B; Kaya T; Bagcivan I; Kaloglu C; Guvenal T; Cetin A; Soydan AS
    Eur J Pharmacol; 2004 Feb; 485(1-3):289-98. PubMed ID: 14757153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrest of mouse preterm labor until term delivery by combination therapy with atosiban and mundulone, a natural product with tocolytic efficacy.
    Siricilla S; Hansen CJ; Rogers JH; De D; Simpson CL; Waterson AG; Sulikowski GA; Crockett SL; Boatwright N; Reese J; Paria BC; Newton J; Herington JL
    Pharmacol Res; 2023 Sep; 195():106876. PubMed ID: 37536638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin inhibitors in preterm labour.
    Loudon JA; Groom KM; Bennett PR
    Best Pract Res Clin Obstet Gynaecol; 2003 Oct; 17(5):731-44. PubMed ID: 12972011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor.
    Serradeil-Le Gal C; Valette G; Foulon L; Germain G; Advenier C; Naline E; Bardou M; Martinolle JP; Pouzet B; Raufaste D; Garcia C; Double-Cazanave E; Pauly M; Pascal M; Barbier A; Scatton B; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 2004 Apr; 309(1):414-24. PubMed ID: 14722330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delay of preterm birth in sheep by THG113.31, a prostaglandin F2alpha receptor antagonist.
    Hirst JJ; Parkington HC; Young IR; Palliser HK; Peri KG; Olson DM
    Am J Obstet Gynecol; 2005 Jul; 193(1):256-66. PubMed ID: 16021088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor.
    Paul JW; Hua S; Ilicic M; Tolosa JM; Butler T; Robertson S; Smith R
    Am J Obstet Gynecol; 2017 Mar; 216(3):283.e1-283.e14. PubMed ID: 27567564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor.
    Croci T; Cecchi R; Marini P; Rouget C; Viviani N; Germain G; Guagnini F; Fradin Y; Descamps L; Pascal M; Advenier C; Breuiller-Fouché M; Leroy MJ; Bardou M
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1118-26. PubMed ID: 17351104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of combined tocolysis on in vitro uterine contractility in preterm labour.
    Kuć P; Laudański P; Pierzyński P; Laudański T
    Adv Med Sci; 2011; 56(1):88-94. PubMed ID: 21555303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination tocolytic effect of magnesium sulfate and an oxytocin receptor antagonist in myometrium from singleton and twin pregnancies.
    Arrowsmith S; Neilson J; Wray S
    Am J Obstet Gynecol; 2016 Dec; 215(6):789.e1-789.e9. PubMed ID: 27555315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour.
    Olson DM; Ammann C
    Front Biosci; 2007 Jan; 12():1329-43. PubMed ID: 17127385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the prostaglandin F2α receptor for preventing preterm labor with azapeptide tocolytics.
    Bourguet CB; Goupil E; Tassy D; Hou X; Thouin E; Polyak F; Hébert TE; Claing A; Laporte SA; Chemtob S; Lubell WD
    J Med Chem; 2011 Sep; 54(17):6085-97. PubMed ID: 21774512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth.
    Arman BM; Binder NK; de Alwis N; Beard S; Debruin DA; Hayes A; Tong S; Kaitu'u-Lino TJ; Hannan NJ
    Sci Rep; 2023 Apr; 13(1):5646. PubMed ID: 37024530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing In Vitro Potencies of Tocolytics and Progesterone in Myometrium From Singleton and Twin Pregnancies.
    Arrowsmith S; Neilson J; Bricker L; Wray S
    Reprod Sci; 2016 Jan; 23(1):98-111. PubMed ID: 26239389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.